Cheng CC, Wooten J, Gibbs ZA, McGlynn K, Mishra P, Whitehurst AW,
2020 Sep
Elife
9
Gibbs ZA, Reza LC, Cheng CC, Westcott JM, McGlynn K, Whitehurst AW,
2020 Jun
Elife
9
Nichols BA, Oswald NW, McMillan EA, McGlynn K, Yan J, Kim MS, Saha J, Mallipeddi PL, LaDuke SA, Villalobos PA, Rodriguez-Canales J, Wistuba II, Posner BA, Davis AJ, Minna JD, MacMillan JB, Whitehurst AW
2018 Sep
Cancer Res.
Emerging Contributions of Cancer/Testis Antigens to Neoplastic Behaviors.
Gibbs ZA, Whitehurst AW 2018 Oct Trends Cancer 10 4 701-712
Maxfield KE, Taus PJ, Corcoran K, Wooten J, Macion J, Zhou Y, Borromeo M, Kollipara RK, Yan J, Xie Y, Xie XJ, Whitehurst AW
2015
Nat Commun
6
8840
Delgado M, Gallegos Z, Stippec S, McGlynn K, Cobb MH, Whitehurst AW,
2024 May
J Biol Chem
107380
Marquez-Palencia M, Reza Herrera L, Parida PK, Ghosh S, Kim K, Das NM, Gonzalez-Ericsson PI, Sanders ME, Mobley BC, Diegeler S, Aguilera TA, Peng Y, Lewis CM, Arteaga CL, Hanker AB, Whitehurst AW, Lorens JB, Brekken RA, Davis AJ, Malladi S,
2024 Jan
Cancer Res
Herrera LR, Johnson RA, McGlynn K, Gibbs ZA, Davis AJ, Whitehurst AW,
2023 Oct
J Biol Chem
105348
EWSR1-FLI1 activation of the cancer/testis antigen FATE1 promotes Ewing sarcoma survival.
Gallegos ZR, Taus P, Gibbs ZA, McGlynn K, Gomez NC, Davis I, Whitehurst AW, 2019 Apr Mol. Cell. Biol.
Gallolu Kankanamalage S, Lee AY, Wichaidit C, Lorente-Rodriguez A, Shah AM, Stippec S, Whitehurst AW, Cobb MH
2017 Feb
Autophagy
1-2
SIK2 Restricts Autophagic Flux to Support Triple Negative Breast Cancer Survival.
Maxfield K, Macion J, Vankayalapati H, Whitehurst AW 2016 Oct Mol. Cell. Biol.The cancer/testis antigens SPANX-A/C/D and CTAG2 promote breast cancer invasion.
Maine EA, Westcott JW, Prechtl AM, Dang TT, Whitehurst AW, Pearson GW 2016 Feb Oncotarget
Gallolu Kankanamalage S, Lee AY, Wichaidit C, Lorente-Rodriguez A, Shah AM, Stippec S, Whitehurst AW, Cobb MH
2016 Dec
Proc. Natl. Acad. Sci. U.S.A.
50
113
14342-14347
Mechanisms promoting escape from mitotic-stress induced tumor cell death.
Sinnott R, Winters L, Larson B, Mytsa D, Taus P, Cappell KM, Whitehurst AW 2014 May Cancer Res.
Li Z, Pei XH, Yan J, Yan F, Cappell KM, Whitehurst AW, Xiong Y
2014 Apr
Mol. Cell
Yan J, Yan F, Li Z, Sinnott B, Cappell KM, Yu Y, Mo J, Duncan JA, Chen X, Cormier-Daire V, Whitehurst AW, Xiong Y
2014 Apr
Mol. Cell
Cause and Consequence of Cancer/Testis Antigen Activation in Cancer.
Whitehurst AW 2013 Oct Annu. Rev. Pharmacol. Toxicol.
Wang EC, Sinnott R, Werner ME, Sethi M, Whitehurst AW, Wang AZ
2013 Aug
Nanomedicine
Multiple cancer testis antigens function to support tumor cell mitotic fidelity.
Cappell KM, Sinnott R, Taus P, Maxfield K, Scarbrough M, Whitehurst AW 2012 Oct Mol. Cell. Biol. 20 32 4131-40
Whitehurst AW, Xie Y, Purinton SC, Cappell KM, Swanik JT, Larson B, Girard L, Schorge JO, White MA
2010 Oct
Cancer Res.
19
70
7652-61
Symplekin specifies mitotic fidelity by supporting microtubule dynamics.
Cappell KM, Larson B, Sciaky N, Whitehurst AW 2010 Nov Mol. Cell. Biol. 21 30 5135-44Synthetic lethal screen identification of chemosensitizer loci in cancer cells.
Whitehurst AW, Bodemann BO, Cardenas J, Ferguson D, Girard L, Peyton M, Minna JD, Michnoff C, Hao W, Roth MG, Xie XJ, White MA 2007 Apr Nature 7137 446 815-9Harnessing RNAi for analyses of Ras signaling and transformation.
Whitehurst AW, White MA 2006 Meth. Enzymol. 407 259-68
Andreassen TT, Jørgensen PH,
1985
Eur Surg Res
4
17
264-8
Join Our Lab
Be part of the great impact we're having on science and medical care across the globe.
The Whitehurst lab is seeking energetic, dedicated graduate students and post-doctoral fellows to join our groups. Please see below for current projects.